Company Filing History:
Years Active: 2006-2010
Title: Gualberto Ruaño - Innovator in Physiogenomics
Introduction
Gualberto Ruaño is a distinguished inventor based in Milford, Connecticut. With two innovative patents to his name, Ruaño has made significant contributions to the fields of physiogenomics and genetic analysis. His work paves the way for personalized treatment interventions based on individual genetic profiles.
Latest Patents
Ruaño's latest patents exemplify his pioneering approach in the realm of medical science. The first patent is focused on a physiogenomic method for predicting clinical outcomes of treatments in patients. This method encompasses the development of a physiogenomic model through meticulous steps such as selecting genetic markers, identifying significant covariates, and performing association tests. By evaluating an individual’s genetic markers against a database, this innovative approach offers personalized treatment recommendations based on predicted physiological responses.
The second patent involves methods for obtaining and utilizing haplotype data. It introduces comprehensive methods and databases to analyze gene haplotype information, including finding the frequency of haplotypes in the population and predicting clinical responses based on an individual's genotype or haplotype. These advancements greatly enhance the understanding of genetic influence on treatment outcomes.
Career Highlights
Gualberto Ruaño has worked with prominent companies such as Genaissance Pharmaceuticals, Inc. and Genomas, Inc. His experience in these organizations has helped propel his research and development in genetic insights and treatment approaches. His expertise is instrumental in driving innovations that recognize the complex interplay between genetics and health.
Collaborations
Throughout his career, Ruaño has collaborated with notable colleagues, including Andreas Windemuth and R. Rex Denton. These collaborations have enriched his projects, allowing for a multidisciplinary approach to problems and solutions in the realm of physiogenomics.
Conclusion
Gualberto Ruaño stands out as a pivotal figure in the advancement of personalized medicine through his innovative patents and interdisciplinary collaborations. His contributions to the understanding of genetic factors in clinical outcomes reinforce the importance of tailored medical treatments based on individual genetic profiles. As research continues to evolve, Ruaño’s work will undoubtedly play a critical role in shaping the future of healthcare.